BKGI logo

Bangkok Genomics Innovation SET:BKGI Stock Report

Last Price

฿1.97

Market Cap

฿1.2b

7D

-11.3%

1Y

n/a

Updated

21 Dec, 2024

Data

Company Financials +

Bangkok Genomics Innovation Public Company Limited

SET:BKGI Stock Report

Market Cap: ฿1.2b

BKGI Stock Overview

Provides clinical and genomics services in Thailand. More details

BKGI fundamental analysis
Snowflake Score
Valuation3/6
Future Growth5/6
Past Performance0/6
Financial Health6/6
Dividends0/6

Rewards

Trading at 72.4% below our estimate of its fair value

Earnings are forecast to grow 23.16% per year

Revenue grew by 13.8% over the past year

Risk Analysis

High level of non-cash earnings

Less than 3 years of financial data is available

Does not have a meaningful market cap (THB1B)

Volatile share price over the past 3 months compared to the TH market


My Notes

Capture your thoughts, links and company narrative

Bangkok Genomics Innovation Public Company Limited Competitors

Dental Corporation

SET:D

฿1.0b

Genesis Fertility Center

SET:GFC

฿1.5b

Inspire IVF

SET:IVF

฿704.0m

KT Medical Service

SET:KTMS

฿612.0m

Price History & Performance

Summary of share price highs, lows and changes for Bangkok Genomics Innovation
Historical stock prices
Current Share Price฿1.97
52 Week High฿5.65
52 Week Low฿1.67
Beta0
1 Month Change-8.80%
3 Month Change-32.07%
1 Year Changen/a
3 Year Changen/a
5 Year Changen/a
Change since IPO-55.23%

Recent News & Updates

Recent updates

Shareholder Returns

BKGITH HealthcareTH Market
7D-11.3%-3.5%-4.7%
1Yn/a-15.5%-3.4%

Return vs Industry: Insufficient data to determine how BKGI performed against the TH Healthcare industry.

Return vs Market: Insufficient data to determine how BKGI performed against the TH Market.

Price Volatility

Is BKGI's price volatile compared to industry and market?
BKGI volatility
BKGI Average Weekly Movement7.2%
Healthcare Industry Average Movement4.1%
Market Average Movement4.3%
10% most volatile stocks in TH Market8.9%
10% least volatile stocks in TH Market2.1%

Stable Share Price: BKGI's share price has been volatile over the past 3 months compared to the TH market.

Volatility Over Time: BKGI's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of TH stocks.

About the Company

FoundedEmployeesCEOWebsite
2017n/an/awww.bangkokgenomics.com

Bangkok Genomics Innovation Public Company Limited provides clinical and genomics services in Thailand. The company offers non-invasive prenatal testing which includes screening for fetal chromosomal abnormalities under the NIFTY brand; and genetic disease carrier screening testing services, such as screening before embryo implantation, carriers of genetic disease, and detection of gene abnormalities associated with thalassemia anemia under the VISTA brand. It also provides real time-PCR test for COVID-19, antigen testing of the COVID-19, SARS-CoV-2 serology testing, SARS-CoV-2 neutralizing antibody testing, and real time-PCR for monkeypox virus testing, as well as HPV DNA test; colon cancer testing under the COLOTECH brand; and individual genetic testing services under the DNALL brand.

Bangkok Genomics Innovation Public Company Limited Fundamentals Summary

How do Bangkok Genomics Innovation's earnings and revenue compare to its market cap?
BKGI fundamental statistics
Market cap฿1.18b
Earnings (TTM)฿44.49m
Revenue (TTM)฿296.39m

26.6x

P/E Ratio

4.0x

P/S Ratio

Is BKGI overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BKGI income statement (TTM)
Revenue฿296.39m
Cost of Revenue฿172.08m
Gross Profit฿124.31m
Other Expenses฿79.82m
Earnings฿44.49m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.074
Gross Margin41.94%
Net Profit Margin15.01%
Debt/Equity Ratio0%

How did BKGI perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/21 07:15
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Bangkok Genomics Innovation Public Company Limited is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Watcharain JongyanyongGloblex Securities Co. Ltd.
Mintra RattayapasKrungsri Securities Public Company Limited